<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The nature of mendelian <z:hpo ids='HP_0000005'>inheritance</z:hpo> assumes that <z:hpo ids='HP_0000001'>all</z:hpo> tissues in which a phenotype of interest is expressed have a uniform diploid karyotype, which is often not the case in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>Owing to nonrandom gains of chromosomes, <z:mp ids='MP_0004027'>trisomies</z:mp> are present in many cases of <z:hpo ids='HP_0001909'>leukemia</z:hpo> and other malignances </plain></SENT>
<SENT sid="2" pm="."><plain>We used polymorphisms in the genes encoding <z:chebi fb="0" ids="35666">thiopurine</z:chebi> S-methyltransferase (TPMT), <z:chebi fb="0" ids="24190">gamma-glutamyl</z:chebi> hydrolase (GGH) and the reduced <z:chebi fb="3" ids="37445">folate</z:chebi> carrier (SLC19A1) to assess the nature of chromosomal acquisition and its influence on genotype-phenotype concordance in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>TPMT and GGH activities in somatic cells were concordant with germline genotypes, whereas activities in <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells were determined by chromosomal number and whether the acquired chromosomes contained a <z:mp ids='MP_0002169'>wild-type</z:mp> or variant allele </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001909'>Leukemia</z:hpo> cells that had acquired an additional chromosome containing a <z:mp ids='MP_0002169'>wild-type</z:mp> TPMT or GGH allele had significantly lower accumulation of thioguanine <z:chebi fb="9" ids="36976">nucleotides</z:chebi> or <z:chebi fb="0" ids="44185">methotrexate</z:chebi> <z:chebi fb="0" ids="53376">polyglutamates</z:chebi>, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Among these genes, there was a comparable number of acquired chromosomes with <z:mp ids='MP_0002169'>wild-type</z:mp> and variant alleles </plain></SENT>
<SENT sid="6" pm="."><plain>Therefore, chromosomal gain can alter the concordance of germline genotype and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:mp ids='MP_0005384'>cell phenotypes</z:mp>, indicating that allele-specific quantitative genotyping may be required to define <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> pharmacogenomics unequivocally </plain></SENT>
</text></document>